ALDH2 inhibitors decrease stroma-induced ALDH activity in AML cells and sensitize them to chemotherapy. by Bin Yuan (19897)

Subjects:

Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy by Ommoleila Molavi (3604277)

“…<p><b>Context:</b> Multiple drug resistance is the major obstacle to conventional chemotherapy. …”

p38 MAPK inhibitor decreases ALDH2 expression in AML cells in the presence of TGF-β1 or stromal cells. by Bin Yuan (19897)

Subjects:

Supplementing NAD+ counters the effects of Oxamate on metabolism and chemotherapy sensitivity. by Siyu Yuan (7425719)

Subjects:

Supplementary Table 2 from Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair by Anna Solta (17387538)

Supplementary Table 1 from Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair by Anna Solta (17387538)

Inhibition of LDHA leads to decreased ATP, reduced AKT phosphorylation, and enhanced chemotherapy sensitivity to LBP in A549 and NCL-H1975 cells. by Siyu Yuan (7425719)

Subjects:

DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf by Bo Li (112195)

DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf by Bo Li (112195)

DataSheet_1_Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf by Bo Li (112195)

DataSheet_1_RETRACTED: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.pdf by Bo Li (112195)

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance training exercise recommendation on average during chemotherapy. by Claire M. Douglas (21238238)

“…<p>Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance training exercise recommendation on average during chemotherapy.…”

Image_2_Nrf2 Overexpression Decreases Vincristine Chemotherapy Sensitivity Through the PI3K-AKT Pathway in Adult B-Cell Acute Lymphoblastic Leukemia.tif by Li Wang (15202)

Subjects:

Image_1_Nrf2 Overexpression Decreases Vincristine Chemotherapy Sensitivity Through the PI3K-AKT Pathway in Adult B-Cell Acute Lymphoblastic Leukemia.tif by Li Wang (15202)

Subjects:

Supporting data for “Androgen receptor modulates chemotherapy response in breast cancer” by Chanping You (9067448)

“…<p dir="ltr">Breast cancer ranks as the second most diagnosed cancer globally and the most common among women. Chemotherapies, encompassing both systemic and targeted approaches, are critical for managing the disease, yet drug resistance often compromises treatment efficacy. …”

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Knockdown of LDHA reduced cell viability and LDH activity in A549 and NCL-H1975 cells, enhancing chemotherapy sensitivity to LBP. by Siyu Yuan (7425719)

Subjects:

Development of a Highly Efficient NIR-II Phototherapeutic Agent for Fluorescence Imaging-Guided Synergistic PTT/PDT/Chemotherapy of Colorectal Cancer by Ji Liu (110659)

“…This study develops a small-molecule NIR-II phototherapeutic agent (IRF) with a high fluorescence quantum yield (17.4%), excellent PCE (96.8%) for photothermal therapy (PTT), and photodynamic therapy (PDT) activity. To decrease thermal resistance during phototherapy, IRF and evodiamine (EVO) were loaded onto hyaluronic acid (HA)-modified nanoparticles, creating a multifunctional nanoplatform termed EVO/IRF@HA NPs. …”

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

DataSheet_1_Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma.docx by Annamaria Massa (3350192)

Subjects: